Drug intelligence / Profile preview

Duanxueliu Tablets

Development stage: Unknown
Lead developer: Anqing Echo Biopharmaceutical
Administration: Oral

Overview

Duanxueliu Tablets are a Traditional Chinese Medicine (TCM) preparation derived from the herb *Clinopodium chinense* (Benth.) O. Kuntze or *Clinopodium polycephalum* (Vaniot) C. Y. Wu & Hsuan ex H. W. Li. The drug is primarily utilized for its potent hemostatic properties, functioning to promote blood coagulation and reduce capillary permeability. It is widely approved in China for the treatment of various bleeding conditions, including excessive menstruation (menorrhagia), functional uterine bleeding, hemoptysis, hematuria, and bleeding associated with uterine fibroids or purpura. The formulation is typically produced as an extract of the single herb, processed into tablet form for oral administration.

Brand names: Duanxueliu Tablets
Other names: 断血流片Duanxueliu PianDuan Xue Liu Pian

Beyond the preview

Go deeper on Duanxueliu Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Duanxueliu Tablets.

Explore the full profile